Revvity

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Revvity and other ETFs, options, and stocks.

About RVTY

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. 

CEO
Prahlad Ramadhar Singh
CEOPrahlad Ramadhar Singh
Employees
11,000
Employees11,000
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1937
Founded1937
Employees
11,000
Employees11,000

RVTY Key Statistics

Market cap
12.76B
Market cap12.76B
Price-Earnings ratio
56.26
Price-Earnings ratio56.26
Dividend yield
0.25%
Dividend yield0.25%
Average volume
1.51M
Average volume1.51M
High today
$115.45
High today$115.45
Low today
$111.87
Low today$111.87
Open price
$115.17
Open price$115.17
Volume
1.56M
Volume1.56M
52 Week high
$128.29
52 Week high$128.29
52 Week low
$81.36
52 Week low$81.36

Stock Snapshot

The current Revvity(RVTY) stock price is $112.50, with a market capitalization of 12.76B. The stock trades at a price-to-earnings (P/E) ratio of 56.26 and offers a dividend yield of 24.9%.

On 2026-01-18, Revvity(RVTY) stock traded between a low of $111.87 and a high of $115.45. Shares are currently priced at $112.50, which is +0.6% above the low and -2.6% below the high.

Revvity(RVTY) shares are trading with a volume of 1.56M, against a daily average of 1.51M.

During the past year, Revvity(RVTY) stock moved between $81.36 at its lowest and $128.29 at its peak.

During the past year, Revvity(RVTY) stock moved between $81.36 at its lowest and $128.29 at its peak.

RVTY News

TipRanks 5d
Revvity Raises 2025 Outlook With Strong Preliminary Results

Claim 70% Off TipRanks Premium Revvity ( (RVTY) ) has shared an announcement. On January 12, 2026, Revvity said it will report its fourth-quarter and full-yea...

Simply Wall St 6d
Why Revvity Is Up 6.4% After New Lilly AI Drug Discovery Partnership Integration

On 9 January 2026, Revvity, Inc. announced a collaboration with Eli Lilly to integrate Lilly’s TuneLab AI/ML predictive drug discovery models into the Revvity S...

Why Revvity Is Up 6.4% After New Lilly AI Drug Discovery Partnership Integration

Analyst ratings

52%

of 21 ratings
Buy
42.9%
Hold
52.4%
Sell
4.8%

People also own

Based on the portfolios of people who own RVTY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .